SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
European Organisation for Research and Treatment of Cancer - EORTC
4,975 participants
May 3, 2017
OBSERVATIONAL
Conditions
Summary
SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
WES, lcWGS and RNAseq, multiplex IF and IMC
WES, RNAseq and EPIC array
NGS panel
NGS panel
ctDNA detection and WES
Locations(136)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02834884